Core Viewpoint - The stock of Renmin Tongtai has experienced a significant price increase, with a cumulative rise of over 20% in the closing prices over three consecutive trading days, indicating unusual trading volatility [1] Company Summary - Renmin Tongtai announced that its stock price increased on July 16, 17, and 18, 2025, with the cumulative closing price increase exceeding 20% [1] - The company conducted a self-examination and confirmed with its controlling shareholder, Harbin Pharmaceutical Group Co., Ltd., that there are no undisclosed significant events or important information [1] - The main business activities of the company include pharmaceutical wholesale, retail, logistics services, and medical services, which have not undergone significant changes [1]